Obatala Sciences Products Featured in Genetic Engineering & Biotechnology News NewsDavid BodeNovember 17, 2022
Obatala Sciences Closes $3 Million Series A Funding Round Co-led by être Venture Capital and Ochsner Health NewsDavid BodeOctober 13, 2022Series A, Investment
Obatala Staff to Present at IFATS Conference NewsDavid BodeSeptember 15, 2022Conference, IFATS, Adipose, MPS